Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Director Declaration
-
CloudMD Announces Closing of Oversubscribed $37.26 Million Bought Deal Public Offering
-
Exagen Inc. To Participate in November Investor Conferences
-
Exagen Inc. To Participate in November Investor Conferences
-
Schultze Special Purpose Acquisition Corp. and Clever Leaves, a Large-Scale Pharmaceutical-Grade Multi-National Cannabis Operator, Announce Revised Transaction Terms
-
Canaccord Genuity Group Inc. Reports Second Quarter Fiscal 2021 Results
-
Inari Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Penumbra, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Issue of Equity
-
Sientra to Participate in Upcoming Virtual Investor Conferences
-
i3 Energy PLC Announces Commencement of Trading on Toronto Stock Exchange
-
Form 8.3 - [RSA Insurance Group plc] - (CGWL)
-
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
-
Intersect ENT to Participate at Upcoming Investor Conferences
-
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update
-
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update
-
Acutus Medical to Participate at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
GlobeX Data Ltd. Closes Private Placement
-
Cybin Completes Reverse Take-Over Transaction
-
Planet 13 Holdings Inc. Announces Closing of C$28.8 Million Bought Deal Public Offering
-
Nanox to Participate in Three Upcoming November 2020 Investor Conferences
-
Nanox to Participate in Three Upcoming November 2020 Investor Conferences
-
Aspira Women’s Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Castle Biosciences to Present at the Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum
-
Agendia to Participate in 2020 Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Looking For Top Penny Stocks To Buy Now? 5 Marijuana Stocks To Watch
-
SeaSpine to Participate in Three Upcoming Investor Conferences
-
DermTech to Participate in Upcoming Investor Conferences
-
LeMaitre Vascular to Present at Upcoming Investor Conferences
-
Axogen, Inc. to Participate at Jefferies Virtual London Healthcare Conference and Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Axogen, Inc. to Participate at Jefferies Virtual London Healthcare Conference and Canaccord Genuity Virtual MedTech & Diagnostics Forum
-
Form 8.3 - [SDL plc] - (HHL)
-
Form 8.3 - [RWS Holdings plc] - (HHL)
-
Form 8.3 - [RWS Holdings plc] - (CGWL)
-
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November and December
-
Tactile Medical to Participate in Upcoming Investor Conferences in November and December
-
GGL Resources Corp. Closes Private Placement
-
Transaction in Own Shares
-
Net Asset Value(s)
-
Pulmonx to Present at Upcoming Investor Conferences
-
Pulmonx to Present at Upcoming Investor Conferences
-
Form 8.3 - [RWS Holdings plc] - (CGWL)
-
Real Estate & E-Commerce Split Corp. Announces Exchange Ratios
-
InMode to Present at Upcoming Virtual Investor Conferences in November
-
Form 8.3 - [RWS Holdings plc] - (CGWL)
-
Total voting rights
-
Yamana Gold Expands Its Footprint in the Abitibi Region With Friendly Acquisition of Monarch
-
Yamana Gold Expands Its Footprint in the Abitibi Region With Friendly Acquisition of Monarch
-
Biodesix Announces Closing of Initial Public Offering
-
Absolute Announces Closing of US$69 Million Public Offering of Common Shares, Including Full Exercise of Underwriters’ Over-Allotment Option

